Results 151 to 160 of about 844,682 (297)
Urofacial Syndrome: A Subset of Neurogenic Bladder Dysfunction Syndromes?
The urofacial syndrome (Ochoa syndrome) is considered to represent a subgroup of the non-neurogenic bladder dysfunction, characterized by non-neuropathic bladder-sphincter dysfunction, along with a characteristic inversion of the facial expression with ...
Tyritzis, S. +3 more
core
ABSTRACT Background and Methods The role of early and increased activity on postoperative recovery is well established, yet the impact of its day‐to‐day variability remains unclear. This retrospective cohort study examined associations between early in‐hospital postoperative physical activity trajectories and postoperative outcomes among 218 surgical ...
Ella Jansen +4 more
wiley +1 more source
Beyond Joint Hypermobility: Investigating Bladder Dysfunction in Hypermobile Ehlers-Danlos Syndrome. [PDF]
Ansari M +5 more
europepmc +1 more source
ABSTRACT This study retrospectively analyzed 92 patients who underwent negative‐pressure suction sheath‐assisted flexible ureteroscopic lithotripsy (observation group) and 85 patients who underwent conventional flexible ureteroscopic lithotripsy (control group).
Ren‐Hui Qiu +4 more
wiley +1 more source
Data‐Independent Acquisition Mass Spectrometry in Tumor Classification and Cancer Biomarker Research
Abstract Cancer treatment is far from optimal also because current classification systems do not reflect the complex molecular status of the tumor and its phenotype in sufficient detail. To construct molecular tumor classifiers, omics tools provide complex molecular data reflecting many aspects from genotype to phenotype.
Jan Simonik +3 more
wiley +1 more source
Dynamic Urothelial Remodeling in Diabetic Bladder Dysfunction: Disease-Course Changes, Molecular Mechanisms, and Clinical Implications. [PDF]
Song Q +6 more
europepmc +1 more source
ABSTRACT The use of MALDI mass spectrometry for the analysis of carbohydrates and glycoconjugates is a well‐established technique and this comprehensive review is the twelfth update of the original article published in 1999 and brings coverage of the literature to the end of 2024.
David J. Harvey
wiley +1 more source
Real-world data on the prevalence and therapy of symptomatic bladder dysfunction in people with multiple sclerosis. [PDF]
Kirstein M +13 more
europepmc +1 more source
Abstract Background Lower urinary tract symptoms (LUTS) are among the most prevalent nonmotor complaints across the parkinsonian spectrum, yet they remain underutilized as diagnostic and management signals in neurology practice. Although prior reviews have characterized disease‐specific patterns of urinary dysfunction, and recent guidelines address ...
Saar Anis +3 more
wiley +1 more source
Estradiol Ameliorates Postmenopausal Bladder Dysfunction by Restoring Mitophagy via the miRNA-200/KLF4/mTOR Signaling Pathway. [PDF]
Chueh KS +12 more
europepmc +1 more source

